companydata.dkcompanydata.dk

POLYPEPTIDE LABORATORIES A/S: Financial statements 2024

CVR: 19056201

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

POLYPEPTIDE LABORATORIES A/S (CVR 19056201) has filed annual accounts for 2024. In 2024, the company reported a net result of DKK 7,060,000 compared with DKK 3,229,000 the year before. Equity in the 2024 report amounted to DKK 72,867,000. The solvency ratio was 100%.

Profit/Loss
DKK 7,060,000
Equity
DKK 72,867,000
Total Assets
DKK 72,888,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--7.1 mio.72.9 mio.-
2023--3.2 mio.65.8 mio.-
2022---3 mio.62.6 mio.-
2021---839 t.65.6 mio.-
2020-01.3 mio.66.5 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

POLYPEPTIDE LABORATORIES A/S: The 2023 annual report is outJun 27, 2024

POLYPEPTIDE LABORATORIES A/S has published its annual report for 2023. The net result was DKK 3,229,000.

About POLYPEPTIDE LABORATORIES A/S

POLYPEPTIDE LABORATORIES A/S is a Danish company of the type Aktieselskab based in Hillerød, founded in 1996. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named A/S PSE NR. 4948. The management consists of Raoul Bernhardt. The board consists of Juan José Gonzalez Casanova (chair), Christina Ellen Del Vecchio and Raoul Bernhardt. The company is owned by PolyPeptide Laboratories Holding (PPL) AB. The company has 0 employees (2017). In 2025, the company reported a net result of DKK 2,632,000 compared with DKK 7,060,000 the year before. Equity in the 2025 report amounted to DKK 75,499,000.

Source: annual report 2025, Danish Business Authority